The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer

This publication has 38 references indexed in Scilit:

• The integration of docetaxel into first-line chemotherapy for ovarian cancer
  International Journal of Gynecologic Cancer, 2001
• Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
  JNCI Journal of the National Cancer Institute, 2000
• Paclitaxel vs Epidoxorubicin plus Paclitaxel as Second-Line Therapy for Platinum-Refractory and -Resistant Ovarian Cancer
  Gynecologic Oncology, 1999
• Gynaecological Cancer
  Annals of Oncology, 1998
• Taxol given weekly in advanced previously treated ovarian carcinomas - a pilot study
  International Journal of Gynecologic Cancer, 1997
• Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer
  Annals of Oncology, 1996
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• 254-S, NK121 and TRK710
  Published by Springer Nature ,1996
• Carboplatin versus cisplatin
  Annals of Oncology, 1993
• Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.
  BMJ, 1991